Jessica Roth

NPI: 1407327224
Total Payments
$11,855
2024 Payments
$3,885
Companies
40
Transactions
492
Medicare Patients
1,099
Medicare Billing
$90,367

Payment Breakdown by Category

Food & Beverage$11,242 (94.8%)
Travel$362.60 (3.1%)
Education$250.09 (2.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $11,242 484 94.8%
Travel and Lodging $362.60 3 3.1%
Education $250.09 5 2.1%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $2,223 92 $0 (2024)
Janssen Biotech, Inc. $1,217 56 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $1,209 75 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $1,033 41 $0 (2024)
Enterra Medical, Inc. $810.41 6 $0 (2024)
Janssen Scientific Affairs, LLC $636.13 6 $0 (2024)
Celgene Corporation $483.80 31 $0 (2024)
Daiichi Sankyo Inc. $470.27 18 $0 (2023)
E.R. Squibb & Sons, L.L.C. $403.59 4 $0 (2023)
Intercept Pharmaceuticals, Inc. $392.80 18 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $3,885 135 ABBVIE INC. ($915.83)
2023 $3,426 155 ABBVIE INC. ($716.78)
2022 $2,895 126 ABBVIE INC. ($507.46)
2021 $1,650 76 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($398.20)

All Payment Transactions

492 individual payment records from CMS Open Payments — Page 1 of 20

Date Company Product Nature Form Amount Type
12/19/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $15.29 General
Category: LIVER DISEASE
12/18/2024 Enterra Medical, Inc. Food and Beverage In-kind items and services $20.80 General
12/16/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $19.82 General
Category: IMMUNOLOGY
12/11/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $23.84 General
Category: IMMUNOLOGY
12/10/2024 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $26.55 General
Category: THERAPY FOR CSID
12/09/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $18.76 General
Category: IMMUNOLOGY
12/04/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $16.70 General
Category: Immunology
12/04/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $16.67 General
Category: Gastroenterology
12/03/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $17.46 General
Category: INFLAMMATION AND IMMUNOLOGY
11/19/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $19.92 General
Category: GI
11/19/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $2.42 General
Category: Gastroenterology
11/12/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $20.18 General
Category: IMMUNOLOGY
11/07/2024 ABBVIE INC. CREON (Drug) Food and Beverage In-kind items and services $7.46 General
Category: ENDOCRINOLOGY
11/07/2024 Intercept Pharmaceuticals, Inc. OCALIVA (Drug) Food and Beverage In-kind items and services $5.71 General
Category: Hepatology / Gastroenterology
11/04/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC TRULANCE (Drug) Food and Beverage In-kind items and services $28.41 General
Category: Gastroenterology
11/04/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $17.65 General
Category: IMMUNOLOGY
10/30/2024 VIVUS LLC QSYMIA (Drug) Food and Beverage In-kind items and services $15.90 General
Category: ENDOCRINOLOGY
10/30/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $11.16 General
Category: Immunology
10/29/2024 Takeda Pharmaceuticals U.S.A., Inc. EOHILIA (Drug) Food and Beverage In-kind items and services $20.19 General
Category: INTERNAL MEDICINE
10/28/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $13.18 General
Category: Immunology
10/24/2024 AIMMUNE THERAPEUTICS, INC. ZENPEP (Drug) Food and Beverage In-kind items and services $13.56 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
10/17/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $30.87 General
Category: IMMUNOLOGY
10/16/2024 Enterra Medical, Inc. Travel and Lodging In-kind items and services $113.05 General
10/16/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $13.21 General
Category: Gastroenterology
10/15/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $6.14 General
Category: GASTROENTEROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 356 368 $81,661 $26,310
2022 5 358 374 $87,690 $26,750
2021 3 385 402 $103,580 $37,307
Total Patients
1,099
Total Services
1,144
Medicare Billing
$90,367
Procedure Codes
13

All Medicare Procedures & Services

13 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 141 148 $32,116 $11,028 34.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 82 82 $27,224 $8,031 29.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 90 95 $14,060 $4,901 34.9%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 26 26 $5,694 $1,788 31.4%
99202 New patient office or other outpatient visit, 15-29 minutes Office 2023 17 17 $2,567 $562.36 21.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 143 156 $33,835 $10,782 31.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 102 102 $33,864 $9,565 28.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 56 59 $8,732 $3,289 37.7%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 39 39 $8,541 $2,378 27.8%
99202 New patient office or other outpatient visit, 15-29 minutes Office 2022 18 18 $2,718 $736.02 27.1%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 162 162 $53,784 $17,618 32.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 190 202 $44,172 $17,330 39.2%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 33 38 $5,624 $2,359 41.9%

About Jessica Roth

Jessica Roth is a Nurse Practitioner healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/06/2018. The National Provider Identifier (NPI) number assigned to this provider is 1407327224.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jessica Roth has received a total of $11,855 in payments from pharmaceutical and medical device companies, with $3,885 received in 2024. These payments were reported across 492 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($11,242).

As a Medicare-enrolled provider, Roth has provided services to 1,099 Medicare beneficiaries, totaling 1,144 services with total Medicare billing of $90,367. Data is available for 3 years (2021–2023), covering 13 distinct procedure/service records.

Practice Information

  • Specialty Nurse Practitioner
  • Location Fort Worth, TX
  • Active Since 12/06/2018
  • Last Updated 04/27/2021
  • Taxonomy Code 363L00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1407327224

Products in Payments

  • STELARA (Biological) $1,452
  • XIFAXAN (Drug) $1,006
  • RINVOQ (Biological) $918.38
  • ENTYVIO (Biological) $836.17
  • ZEPOSIA (Drug) $833.04
  • SKYRIZI (Biological) $770.97
  • INJECTAFER (Drug) $470.27
  • OCALIVA (Drug) $392.80
  • DUPIXENT (Biological) $385.67
  • Talicia (Drug) $283.87
  • TREMFYA (Drug) $267.96
  • IBSRELA (Drug) $236.46
  • CREON (Drug) $231.13
  • TRULANCE (Drug) $190.04
  • HUMIRA (Biological) $168.82
  • RENFLEXIS (Drug) $165.04
  • DIFICID (Drug) $150.82
  • GIMOTI (Drug) $147.16
  • MONOFERRIC (Drug) $145.45
  • Linzess (Drug) $140.17

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nurse Practitioner Doctors in Fort Worth